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IMPORTANCE Self-guided internet-based cognitive behavioral therapy (iCBT) has the
potential to increase access and availability of evidence-based therapy and reduce the cost of
depression treatment.
OBJECTIVES To estimate the effect of self-guided iCBT in treating adults with depressive
symptoms compared with controls and evaluate themoderating effects of treatment
outcome and response.
DATA SOURCES A total of 13 384 abstracts were retrieved through a systematic literature
search in PubMed, Embase, PsycINFO, and Cochrane Library from database inception to
January 1, 2016.
STUDY SELECTION Randomized clinical trials in which self-guided iCBTwas compared with a
control (usual care, waiting list, or attention control) in individuals with symptoms of
depression.
DATA EXTRACTION AND SYNTHESIS Primary authors provided individual participant data from
3876 participants from 13 of 16 eligible studies. Missing data were handled using multiple
imputations. Mixed-effects models with participants nested within studies were used to
examine treatment outcomes andmoderators.
MAIN OUTCOMES ANDMEASURES Outcomes included the Beck Depression Inventory, Center
for Epidemiological Studies–Depression Scale, and 9-item Patient Health Questionnaire
scores. Scales were standardized across the pool of the included studies.
RESULTS Of the 3876 study participants, the mean (SD) age was 42.0 (11.7) years, 2531
(66.0%) of 3832 were female, 1368 (53.1%) of 2574 completed secondary education, and
2262 (71.9%) of 3146 were employed. Self-guided iCBT was significantly more effective than
controls on depressive symptoms severity (β = −0.21; Hedges g = 0.27) and treatment
response (β = 0.53; odds ratio, 1.95; 95% CI, 1.52-2.50; number needed to treat, 8).
Adherence to treatment was associated with lower depressive symptoms (β = −0.19;
P = .001) and greater response to treatment (β = 0.90; P < .001). None of the examined
participant and study-level variables moderated treatment outcomes.
CONCLUSIONS AND RELEVANCE Self-guided iCBT is effective in treating depressive symptoms.
The use of meta-analyses of individual participant data provides substantial evidence for
clinical and policy decisionmaking because self-guided iCBT can be considered as an
evidence-based first-step approach in treating symptoms of depression. Several limitations of
the iCBT should be addressed before it can be disseminated into routine care.
JAMA Psychiatry. doi:10.1001/jamapsychiatry.2017.0044
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M
any studies1-4 have found that depressive symp-
toms can be effectively treated with psycho-
therapy, pharmacotherapy, or both. Nevertheless,
manypeoplewithdepressive symptomsdonot seekhelp, and
evenwell-resourcedhealthcaresystemsfind itdifficult tomar-
shal enough qualified therapists to offer psychological inter-
ventions. Access barriers to psychotherapy include limited
availability of trained clinicians, high cost of treatment, and
fear of stigmatization.5-8Asa consequence, a significantnum-
ber of individuals with depressive symptoms remain
untreated.9,10
Self-guided internet-based cognitive behavioral therapy
(iCBT) without therapist support can allow physicians, such
as general practitioners, to provide easy and affordable ac-
cess to psychological treatments and reduce the cost of such
treatments. Ameta-analysis11 founda small but significant ef-
fect size of self-guided iCBT compared with control condi-
tions.However, recent large trials foundarangeofeffects,vary-
ing from small to moderate effect sizes12,13 to no effect.14,15
These contradicting findings drewmuch attention and raised
concerns about the benefits of these interventions.
Randomized clinical trials (RCTs) and study-level system-
atic reviews often lack adequate power and precision in their
estimates. Statistically underpowered samples also preclude
identification of clinically useful moderators or predictors of
treatment outcome.16Meta-analyses using individual partici-
pant data (IPD) estimate aggregate effect sizes using IPD from
RCTs. The IPD maximize power to detect a true effect while
allowing the exploration of study variability (eg, level of sup-
port, treatment adherence, setting) andparticipant character-
istics asmoderators of treatment outcome. Thepresent study
reports the results of an IPD meta-analysis of trials on self-
guided iCBT for adult depressive symptoms compared with
control conditions.The term self-guided iCBT is definedasCBT
deliveredvia the internet,whichmay involveautomated feed-
back but does not provide support related to the therapeutic
content.
Methods
Eligibility Criteria
Studieswere included if theparticipantswere adults (aged>18
years)with elevated symptomsofdepressionbasedonanydi-
agnosis or any self-report scaleofdepression.Only thoseRCTs
in which self-guided iCBT was compared with a control con-
dition (usual care, waiting list, or attention control) were in-
cluded. No language or publication status exclusions were
applied.
Study Identification and Selection Process
The analysis was completed in compliance with the Pre-
ferred Reporting Items for Systematic Review and Meta-
analyses (PRISMA) IPD Statement.17 We used an existing da-
tabase on psychological treatments for depression18 that is
updated annually by a systematic literature search in the bib-
liographicdatabasesofPubMed,Embase,PsycINFO,andCoch-
rane Library (from inception to January 1, 2016). In these
searches, various index and free terms of psychotherapy and
depression are used in different combinations (full search
strings forPubMedareprovided in theeMethods in theSupple-
ment). Two researchers (P.C. and E.K.) independently exam-
ined titles andabstracts of 13 384articles. The full text of stud-
ies that possiblymet the inclusion criteria according to 1 of the
2 reviewers was retrieved. In case of disagreement regarding
inclusion, consensuswas sought throughdiscussion.We also
asked key researchers in the field whether they knew of un-
published trials.
Data Collection and Data Items
Authors of eligible articles were contacted for permission to
use their data sets. Reminders were sent after 2 weeks and if
necessary after 1 month. If no response was received, we ex-
cluded the trial. Authors were asked to provide data on so-
ciodemographic, clinical, and intervention characteristics, in-
cluding informationregarding randomizedgroup,baselineand
follow-up total scores of depressive symptoms, treatment ad-
herence information (total number of sessions completed di-
vided by total number of treatment sessions), age, sex, edu-
cational level (primary, secondary, and tertiary education),
employment status (employed or unemployed), relationship
status (in a relationship or not), and comorbid anxiety symp-
toms at baseline (yes or no; based on a clinical interviewor el-
evatedanxiety symptoms ratingson self-reportmeasures). Fi-
nally,we combined all individual data sets into amergeddata
set, using a generic standardized protocol for integrating IPD
sets.1 We also used study-level variables, which were avail-
able from the full reports (type of comparator condition, re-
cruitment, level of support). The selection ofmoderator vari-
ables has been based on previous literature related to
moderators of face-to-face CBT or iCBT.16,19
Risk of Bias Assessment in Individual Studies
Weexamined the risk of bias in the included studies using the
criteria of the Cochrane Collaboration risk of bias assessment
tool.20 Two independent reviewers (E.K., P.C.) evaluated the
includedstudies todeterminewhether therewasa risk forbias
related toselection,performance,detection, attrition, andout-
come reporting. In case of unclear risk of bias for 1 ormore key
domains, we contacted the first authors of the included stud-
ies for clarifications.
Key Points
Questions Is self-guided internet-based cognitive behavioral
therapy effective in treating depressive symptoms and which
variables moderate treatment outcome?
Findings In this meta-analysis of individual participant data from
3876 adults, internet-based cognitive behavioral therapy was
more effective compared with controls. Adherence predicted
better treatment outcomes within the experimental condition.
Meaning Self-guided internet-based cognitive behavioral therapy
may be a viable alternative to current first-step treatment
approaches for symptoms of depression, particularly in those
individuals who are not willing to have any therapeutic contact.
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Traditional Meta-analysis
We conducted a traditional meta-analysis to examine differ-
ences among the 13 studies that provided the IPD and the 3
studies that did not. We used data reported in the articles to
calculate the effect sizes (Hedges g).21 The reader is referred
to the eMethods in the Supplement for details regarding the
methods of the traditional meta-analysis.
IPDMeta-analysis
Studies included in this IPDmeta-analysisusedmeasures such
as theCenterofEpidemiologicStudies–DepressionScale,22 the
BeckDepression Inventory I23 or II,24 (hereafter referred to as
Beck Depression Inventory) or the 9-item Patient Health
Questionnaire25 tomonitor change indepressivesymptomsse-
verity.Thesedepressionmeasureswere standardizedby trans-
formation into z scores across the pool of the studies before
conducting the main analysis.
Missing outcome data at the posttreatment assessment
were estimatedusingmultiple imputationunder themissing-
at-randomassumption(mi imputemvninSTATAsoftware,ver-
sion 13.1; StataCorp).Thismethodgenerated 100 imputeddata
sets using data on baseline depressive symptoms scores, age,
sex, andgroup. Thesenew imputeddata sets included theob-
served and the imputed standardized depressive symptoms
scores for themissing values. They were analyzed separately
using the selected model, and the results were averaged ac-
cording toRubin’s rules.26Wealsoconductedsensitivityanaly-
ses using only participants with complete data after treat-
ment toexaminewhether therewasadifferencebetweenthose
who dropped out of the RCTs and those who provided post-
treatment data.
In a 1-stage IPDmeta-analysis, wemerged all IPD from all
studieswithparticipantsnestedwithin studies.One-stage IPD
meta-analysis yields more precise and less biased estimates
of effect, maximizes the power, and accounts for parameter
correlation.27,28We calculated the standardized β coefficient
for the examined comparisons. This estimate indicates how
many SDs the dependent variable (depressive symptoms se-
verityor the logodds ratio [OR]of treatment response) changes
per SD increase in the predictor variable. Thus, the higher the
β is the greater the effect of the predictor variable on the de-
pendent variable, although there is no association among the
variables if theβ is0.All analyseswere conductedwith STATA
statistical software, version 131. The primary analysis was
2-fold. First, we analyzed the effects of the interventions on
depressive symptom severity at the end of treatment using a
multilevelmixed-effects linear regression (using a random in-
tercepts model with a random effect for each trial and fixed
effects for the intervention and the symptoms severity, using
STATA’s mixed command). The posttreatment depression
scoreswere used as thedependent variable and trial armcon-
dition (treatmentvscontrol) as the independentvariable,while
controlling for baseline depressive symptom severity.
Second, we analyzed the effects of the interventions on
treatment response (definedasa50%reduction inbaselinede-
pressive symptoms scores) at the posttreatment assessment
usingamultilevelmixed-effects logistic regression (usingaran-
dom interceptsmodel with a random effect for each trial and
fixed effects for the intervention and the depressive symp-
toms severity, using STATA’s melogit command). The re-
sponse (yes or no)was the dependent variable, and condition
was the independent variable.
Third,werana2-stage IPDmeta-analysisanalyzing the IPD
separately in each study and then combining the estimates to
calculate thepooledeffectsizes (Hedgesg) fordepressivesymp-
toms severity. Two-stage IPDmeta-analysis facilitates analy-
sis standardization across the included studies and estima-
tionofoutcomes thatarenotavailable in thepublishedreports,
such as treatment response.29 Similarly,we calculated theOR
of treatment response and numbers needed to treat (NNTs),
which allowed us to compare the results of the presentmeta-
analysis with those reported in earlier meta-analyses. In ad-
dition, 2-stage IPDmeta-analysis also allowed us to examine
themoderationeffectof study-levelvariables.Thus, subgroup-
moderator analyses were conducted using a mixed-effects
model in which the random-effects model was used to pool
studies within subgroups, whereas between-subgroup
differences were tested as fixed effects. We also ran meta-
regression analyses to examine the associationbetween treat-
ment duration and treatment outcomes (severity of depres-
sive symptoms and treatment response).
Exploration of Variation in Effects:
Participant-Level Moderators
We tested whether available demographic and clinical char-
acteristics moderated the effect of self-guided iCBT on de-
pression outcomes (depressive symptoms severity and treat-
ment response). Not all included studies reported data on the
examinedmoderators (forprecisenumbers regarding themiss-
ing data, seeTable 1 andTable 2). To examinemoderators,we
added the interaction between each potential moderator and
treatment outcome on depression severity into the multi-
levelmixed-effects linear regressionmodel.Wesimilarlyadded
the interaction between each potential moderator and treat-
ment response into the multilevel mixed-effects logistic re-
gression model. Each potential moderator was included in a
separate model as a main effect.
Treatment Adherence as a Predictor
Within the Treatment Group
Weexaminedwhetheradherencetotreatmentpredictedwithin
treatmentgroupeffect size for theexperimental conditiononly,
usinga linearmixedmodel,which regressedposttreatmentde-
pressive symptomsseverityon treatmentadherenceandbase-
linedepressivesymptomsseverity (fixedeffects)andusingran-
dom intercepts for the studies. Treatment adherence was
defined as the total number of sessions that each participant
completed divided by the total number of treatment ses-
sions.
Results
Study Selection and IPDObtained
The systematic search resulted in 16 eligible articles of 1885
full-text articles screened. We were able to obtain IPD from
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13 of the 16 eligible trials (81%), yielding a total of 3876
participants.12,14,15,30-38 Three eligible data sets39-41were un-
available and thus could not be included in the IPD meta-
analyses. Figure 1 shows the study selection process.
Study and Participant Characteristics
Seven of the included studies30,31,34,35,37,38 recruited partici-
pants through the community. The included RCTs examined
iCBT,with interventionscomprising5to11onlinesessions.Four
of the included trials provided support related to the techni-
cal aspects of the online platforms,15,31,33,36 whereas 9 trials
were purely self-guided.12-14,30,32,34,35,37,38The control condi-
tionsusedwere attentionplacebo, no treatment, treatment as
usual, orwaiting list. The included studieswere conducted in
6countries:Australia,Germany, Spain, Switzerland, theNeth-
erlands, and theUnitedKingdom (eTable 1 in the Supplement
presents a summary of study characteristics).
Of the3876studyparticipants, themean (SD) agewas42.0
(11.7) years, 2531 (66.0%) of 3832were female, 1368 (53.1%) of
2574completedsecondaryeducation,and2262 (71.9%)of3146
were employed. The mean baseline depressive symptoms
scores were 25.7 on the Center of Epidemiologic Studies–
Depression Scale, 28.3 on theBeckDepression Inventory, and
14.1 on the 9-item Patient Health Questionnaire in their re-
spective studies. Finally, 71 (1.8%) of 3876 randomized par-
ticipants did not start the treatment or did not provide base-
lineandposttreatmentdata, and1048 (27.0%)of3876dropped
out of the RCT and did not provide posttreatment depressive
symptomsscores. (eTable2 in theSupplementprovidesa sum-
mary of participants’ characteristics.)
Table 1. Mixed-EffectsModel Outcomes on Depressive Symptom Severity for 1-Stage Individual Patient Data
Variable
Full Sample Complete Cases Analysisa
No. of Observations
(No. of Studies) Mean (SE) βb
2-Tailed
P Value
No. of Observations
(No. of Studies) Mean (SE) βb
2-Tailed
P Value
Main effects of depression severity
Baseline severity 3795 (13) 0.57 (0.02) <.001 2818 (13) 0.57 (0.02) <.001
Treatment group −0.21 (0.03) <.001 −0.19 (0.03) <.001
Age
Baseline severity 3786 (13) 0.58 (0.02) <.001 2809 (13) 0.57 (0.02)
Treatment group −0.32 (0.10) <.001 −0.33 (0.11) .003
Age × treatment group 0.003(0.002) .28 0.003 (0.002) .19
Sex
Baseline severity 3788 (13) 0.58 (0.02) <.001 2811 (13) 0.57 (0.02) <.001
Treatment group −0.22 (0.03) <.001 −.0.22 (0.04) <.001
Sex × treatment group 0.05 (0.06) .45 0.07 (0.06) .26
Educational level
Baseline severity 2538 (10) 0.58 (.024) <.001 1973 (10) 0.57 (0.02) <.001
Treatment group −0.031 (0.011) <.001 −0.31 (0.12) .00
Educational level × treatment group
Secondary vs primary education 0.15 (0.13) .21 0.19 (0.13) .14
Tertiary vs primary education 0.03 (0.13) .79 0.02 (0.13) .84
Relationship status
Baseline severity 3568 (12) 0.57 (0.02) <.001 2630 (12) 0.56 (0.02) <.001
Treatment group −0.20 (0.05) <.001 −0.18 (0.05) <.001
Relationship status × treatment group 0.006 (0.06) .91 −0.004 (0.06) .95
Employment status
Baseline severity 3067 (10) 0.55 (0.02) <.001 2194 (10) 0.53 (0.02) <.001
Treatment group −0.27 (0.06) <.001 −0.26 (0.07) <.001
Employment status × treatment group 0.12 (0.08) .11 0.14 (0.08) .07
Comorbid anxiety
Baseline severity 1728 (9) 0.62 (0.03) <.001 1447 (9) 0.62 (0.03) <.001
Treatment group −0.20 (0.05) <.001 −0.19 (0.05) <.001
Comorbid anxiety × treatment group −0.10 (0.07) .17 −0.11 (0.07) .13
Baseline severity of depression
Baseline severity 3795 (13) 0.59 (0.02) <.001 2818 (13) 0.59 (0.02) <.001
Treatment group −0.20 (0.03) <.001 −0.19 (0.03) <.001
Baseline severity × treatment group −0.03 (0.03) .22 −0.04 (0.03) .17
a This is a sensitivity analysis that was conducted including only participants
who completed posttreatment depression questionnaires.
bStandardized β weights of the composite z scores of the Beck Depression
Inventory I or II,23,24 Center for Epidemiological Studies–Depression Scale,22
and 9-item Patient Health Questionnaire.25
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Risk of Bias Assessment
All included studies scored low on all examined items of the
Cochrane risk of bias tool. Randomallocation sequenceswere
adequately generated, and theallocationwas sufficiently con-
cealed in all includedRCTs. Participantswere notmasked be-
cause this is difficult to achieve inpsychotherapy research.All
studiesused self-report outcomemeasures.Missingdatawere
imputed as part of the present IPD to minimize study attri-
tion bias. Finally, studies were assessed as being free of out-
come reporting bias and other sources of bias (eTable 3 in the
Supplement).
Results of Traditional Meta-analysis
Sixteen studies examined the comparison between self-
guided iCBT and control groups. The results of the traditional
meta-analysis revealed that self-guided iCBToutperformedthe
control conditions atposttreatment assessment (g = 0.33; 95%
CI, 0.19-0.46; P < .001). Heterogeneity wasmoderate to high
and significant (I2 = 71%; 95% CI, 51%-82%; P < .001). There
was no significant difference between the outcome findings
of studies included in thepresent IPDmeta-analysis and stud-
ieswith unavailable data (P = .95) (Figure 2). Therewas some
indication of publication bias. With the use of the Duval and
Tweedie trim and fill method, values for 5 studies were im-
putedand thepointestimate reduced to g = 0.21 (95%CI,0.07-
0.34), and theEgger test resultwas significant (P < .001) (eFig-
ure 1 in the Supplement).
One-Stage IPDMeta-analysis:DepressiveSymptomsSeverity
Table 1 presents the main findings of the 1-stage IPD meta-
analysis on depressive symptoms severity after testing (rang-
ing from 6 to 16 weeks after randomization). There was a sig-
nificant effect of self-guided iCBT over control conditions on
depressive symptoms (β = −0.21; P < .001). Complete cases
yieldedsimilaroutcomes (β = −0.19;P < .001).Noneof thepar-
ticipant-level variables (sociodemographic and clinical char-
acteristics) significantly moderated outcome after treatment
(Table 1). However, adherence to treatment predicted signifi-
cantly better outcomes within the self-guided iCBT group
(β = −0.19; P = .001).
Two-Stage IPDMeta-analysis:DepressiveSymptomsSeverity
The 2-stage IPDmeta-analysis resulted in a pooled effect size
of g = 0.27 (95% CI, 0.17-0.37; P < .001) in favor of self-
guided iCBT (eTable 4 in the Supplement). Similar outcomes
were obtained in complete cases analyses (g = 0.32; 95% CI,
Table 2. Outcomes on Treatment Response for 1-Stage Individual Patient Dataa
Variable
Full Sample Complete Cases Analysisa
No. of Observations
(No. of Studies) Mean (SE) βb
2-Tailed
P Value
No. of Observations
(No. of Studies) Mean (SE) βb
2-Tailed
P Value
Main effects of treatment response for
treatment group
3795 (13) 0.53 (0.09) <.001 2818 (13) 0.50 (0.09) <.001
Age
Treatment group 3786 (13) 0.70 (0.32) .04 2809 (13) 0.70 (0.33) .03
Age × treatment group −.004 (0.007) .60 −0.005 (0.007) .53
Sex
Treatment group 3788 (13) 0.56 (0.09) <.001 2811 (13) 0.54 (0.11) <.001
Sex × treatment group −0.07 (0.18) .68 −0.09 (0.18) .61
Educational level
Treatment group 2538 (10) 0.83 (0.36) .03 1973 (10 0.77 (0.38) .04
Educational level × treatment group
Secondary vs primary education −0.40 (0.38) .31 −0.37 (0.41) .36
Tertiary vs primary education −0.16 (0.40) .68 −0.07 (0.42) .85
Relationship status
Treatment group 3568 (12) 0.56 (0.14) <.001 2630 (12) 0.56 (0.14) <.001
Relationship status × treatment group −0.07 (0.18) .71 −0.10 (0.18) .58
Employment status
Treatment group 3067 (10) 0.72 (0.18) <.001 2194 (10) 0.72 (0.20) <.001
Employment status × treatment group −0.34 (0.21) .12 −0.40 (0.22) .07
Comorbid anxiety
Treatment group 1728 (9) 0.61 (0.16) <.001 1447 (9) 0.63 (0.17) <.001
Comorbid anxiety × treatment group 0.23 (0.26) .38 0.27 (0.27) .32
Baseline severity of depression
Treatment group 3795 (13) 0.53 (0.09) <.001 2818 (13) 0.50 (0.09) <.001
Baseline severity × treatment group 0.03 (0.08) .41 −0.023 (0.09) .80
a This is a sensitivity analysis that was conducted including only participants
who completed posttreatment depression questionnaires.
bStandardized β weights of the composite z scores of the Beck Depression
Inventory I or II,23,24 Center for Epidemiological Studies–Depression Scale,22
and 9-item Patient Health Questionnaire.25
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0.17-0.46; P < .001). None of the examined study-level vari-
ables (typeof comparator condition, recruitment, level of sup-
port, and treatment duration) were significantly associated
with treatment outcome (eTable 4, eFigure 2, and eFigure 3
in the Supplement).
One-Stage IPDMeta-analysis: Treatment Response
A significant effect in favor of self-guided iCBT over controls
was found for treatment response (β = 0.53;P < .001) (Table2).
Completecasesanalyses resulted insimilaroutcomes(β = 0.50;
P < .001). None of the sociodemographic and clinical charac-
teristicsofparticipantsweresignificantlyassociatedwith treat-
ment response (Table 2). Treatment adherence significantly
predicted treatment response (β = 0.90; P < .001).
Two-Stage IPDMeta-analysis: Treatment Response
The OR was 1.95 (95% CI, 1.52-2.50; P < .001) in favor of the
self-guided iCBTgroup,which corresponds to aNNTof8 (95%
CI, 6-12) (eTable 5 in the Supplement). Similar outcomeswere
found when we conducted complete case analysis (OR, 1.88;
95%CI, 1.34-2.64;P < .001;NNT, 9; 95%CI, 6-17).Noneof the
examined study-level variables was significantly associated
with treatment response (eTable 5, eFigure 4, and eFigure 5
in the Supplement).
Discussion
In this study,weexaminedtheeffectsof self-guided iCBTonse-
verityandtreatmentresponse.Weaimedto identifymoderators
oftreatmentoutcome.Wefoundthatself-guidediCBThadlower
depressive symptom severity and greater treatment response
comparedwith control conditions after testing. These findings
wererobust incompletecaseanalyses.Treatmentadherencewas
significantlyrelatedtotreatmentoutcomeswithintheself-guided
iCBTgroup.Noneof the examinedparticipant- and study-level
variables significantlymoderated the treatment effect.
The finding that self-guided iCBT results in a significant ef-
fect on depression outcomes is consistent with previous
literature.42 However, the present IPD meta-analysis provides
stronger evidence and improves the precision of the estimates
because of the novel methodologic approach used. Moreover,
previous literature42 did not examine NNTs. The current find-
ings indicate that we need to treat 8 individuals with depres-
sive symptoms with self-guided iCBT to expect a 50% symp-
tom reduction. Although this NNT is relatively large and its
clinical relevance couldbedoubted, it can still have a consider-
able effectwhen large groups of patients use the treatment, es-
pecially considering the low costs of self-guided iCBT.
Figure 1. Preferred Reporting Items for Systematic Review andMeta-analyses (PRISMA) Individual Patient Data
(IPD) Study Selection Process
16 407 Records identified through database searching
PubMed (n = 4562); EMBASE (n = 4243); PsycINFO
(n = 2530); Cochrane Library (n = 5072)
13 Studies for which IPD were provided
3867 Participants for whom data were provided
3 Studies (714 participants) for which IPD were not provided
16 Studies (4578 participants) for which aggregate data
were available
111 Additional studies identified through other sources
including contact with researchers
1869 Studies excluded
593 Other intervention and/or control comparison
390 Companion articles
202 Other
189 Depression is not an inclusion criterion
135 No psychotherapy
113 Protocol articles
95 Maintenance trial
51 No control condition
38 Studies with adolescents
33 No random assignment
19 Stepped care or management program
7 Inpatients
4 Effect sizes cannot be estimated
13 384 Studies after duplicates removed
1885 Studies screened for eligibility
16 Studies for which IPD were sought
13 Studies included in analysis
IPD (report for each main outcome)
3867 Participants included in analysis
71 Participants excluded (baseline data not available)
71 Participants for whom no data were provided
16 Studies included in analysis
3550 Participants included in analysis
1028 Participants excluded (not included in the published
reports)
1028 Participants for whom no data were provided
Aggregate data (report for each main outcome)
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The role of treatment adherence in outcomes has been
identified by a previous review in the field conducted by
Donkinandcolleagues.43Theauthorsconcludedthat thenum-
ber of sessions correlatedwith outcomes in the interventions
that targeted at depressive symptoms.43 In other words, par-
ticipants did better when they adhered to the intervention.
However, treatment adherence follows the course of the in-
tervention andmaybe influencedby response to treatment as
much as vice versa. As previous research findings44have sug-
gested, theremaybedifferent preexisting factors (eg, age and
sex) that influence the association between treatment adher-
ence and treatment outcomes.
It is also interesting that baseline depressive symptoms
scoresdidnotmoderate treatmentoutcomes.This findingcon-
trasts with the findings of the IPD meta-analysis of low-
intensity interventionsbyBoweret al,16whofound thathigher
levelsofdepressivesymptomsatbaselinewereassociatedwith
better depressive outcomes (greater decrease in depressive
symptoms) after the completion of low-intensity interven-
tions. However, this effect was relatively small. The authors
concluded that itmight not be clinically relevant and that it is
safer to assume that low-intensity interventionswork equally
across a range of severities.
Strengths and Limitations
Among the strengths of the present study was its high power
to detect small statistically significant differences between in-
tervention and controls and to yield more precise and robust
evidence compared with traditional meta-analyses. More-
over, the includedRCTshadhighmethodologic quality,which
allows us to be confident that the present analysis is relatively
free of critical biases.However,many internet-delivered inter-
ventions incorporate repeateduseofsymptominventorieswith
eachonline session. This repeated administrationof symptom
inventories might yield lower mean scores with each wave of
measurement (completerbiases relatedtoself-report ratings).45
Moreover, the included studies did not report on recruitment
issues related to large-scale, fully unguided internet-
administered interventions, including factors such as re-
peated registration attempts by individuals who did not meet
inclusion criteria or whowere dissatisfiedwith their interven-
tion allocation. These matters constitute a potential threat to
validityandshouldbeaddressedbyfuture research in this field.
Several limitationsofour IPDmeta-analysis shouldbemen-
tioned. We observed moderate to high heterogeneity. Unfor-
tunately, the subgroup analyses did not provide any indica-
tion of which study-level variables are associated with the
observedheterogeneity.Moreover, our findings are at risk (al-
beit low) of availability bias becausewe could not access data
from 3 eligible studies of the 16. However, the results of the
traditional meta-analysis indicated that the findings of these
3 unavailable trials did not differ from the findings of the in-
cluded RCTs. Another limitation is that we could not exam-
ine duration of symptoms as a potential moderator of treat-
ment outcome. Duration of symptoms is important because
individuals with chronic depressive symptoms may not al-
ways respond rapidly to treatment. Furthermore,most of the
includedtrials recruitedtheir self-referredparticipants through
the community, thereby limiting our ability to generalize the
present results to clinical samples. Finally, therewas some in-
Figure 2. Forest Plot of Traditional Meta-analysis
−0.00 0.500 1.00
Hedges g (95% CI)
−0.50
Favors
Controls
Favors
Self-guided
iCBTSource
No data availability
Data availability
Clarke et al,39 2002
Clarke et al,40 2005
Mean (SE)
Hedges g
0.61 (0.15)
−0.02 (0.13)
0.38 (0.24)
Variance (95% CI)
0.02 (0.31 to 0.91)
0.02 (−0.28 to 0.23)
0.06 (−0.08 to 0.85)
0.31 (0.22) 0.05 (−0.11 to 0.74)
z Value
3.95
−0.18
1.63
1.44
P Value
<.001
.86
.10
.15
2.31 .02
4.50
4.72
3.44 <.001
0.77 .44
3.53 .00
−0.30 .19
1.86 .06
3.31 <.001
4.06 <.001
3.22 <.001
2.31 .02
2.78 .01
0.46 .65
1.89 .06
<.001
<.001
Clarke et al,41 2009
Pooled estimate of 
unavailable data
0.65 (0.28)
0.36 (0.11)
0.09 (0.12)
0.89 (0.25)
−0.13 (0.10)
0.26 (0.14)
0.34 (0.10)
0.64 (0.16)
0.57 (0.18)
0.44 (0.19)
0.43 (0.15)
0.05 (0.11)
0.27 (0.14)
0.08 (0.10 to 1.21)
0.01 (0.16 to 0.57)
0.01 (−0.14 to 0.33)
0.06 (0.40 to 1.38)
0.01 (−0.33 to 0.07)
0.02 (−0.01 to 0.52)
0.01 (0.14 to 0.54)
0.02 (0.33 to 0.94)
0.03 (0.22 to 0.91)
0.04 (0.07 to 0.81)
0.02 (0.13 to 0.73)
0.01 (−0.16 to 0.26)
0.02 (−0.01 to 0.54)
Berger et al,30 2011
de Graaf et al,32 2009
Christensen et al,31 2004
Farrer et al,33 2011
Kleiboer et al,34 2015
Gilbody et al,15 2015
Meyer et al,35 2009
Klein et al,13 2016
Meyer et al,12 2015
Moritz et al,37 2012
Mira et al,36 (In press)
Spek et al,38 2007
0.31 (0.07) 0.05 (0.18 to 0.47)
Pooled estimate of 
available data
0.33 (0.07) 0.00 (0.19 to 0.46)Overall
Phillips et al,14 2014
iCBT indicates internet-based
cognitive behavioral therapy.
Internet-Based Cognitive Behavioral Therapy for Treatment of Depression Original Investigation Research
jamapsychiatry.com (Reprinted) JAMAPsychiatry Published online February 22, 2017 E7
Downloaded From: http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/psych/0/ by a University of York User  on 03/02/2017
Copyright 2017 American Medical Association. All rights reserved.
dicationofpublicationbias, suggesting thatunpublished trials
with negative findings might be missing from the present
sample of studies.
Conclusions
Self-guided iCBT produces results that are encouraging. The
absence of a significant difference in treatment outcomes as-
sociatedwithclinicalandsociodemographiccharacteristics im-
plies thatself-guided iCBTcanbeusedbymost individualswith
depressive symptoms regardless of the severity of their symp-
toms or their sociodemographic background. Currently, anti-
depressant medications are widely used in the treatment of
depressive symptoms, whereas psychotherapeutic interven-
tions are provided to a lesser degree, despite many individu-
als with depressive symptoms preferring psychotherapy to
antidepressants.46However, thehigh treatment costs and the
limited number of trained clinicians hamper the implemen-
tation of psychotherapy in practice.
The findingsof thepresent IPDmeta-analysis suggest that
self-guided iCBT may be a viable alternative to current first-
step treatment approaches for symptoms of depression, par-
ticularly in those individuals who are not willing to have any
therapeuticcontact.This formof interventionseemstobevalu-
able for patientswith primary depressive problems and those
with depressive symptoms in the context of a primary so-
matic problem.47,48 This self-help form of CBT can provide
treatment access at low cost to large numbers of individuals
worldwidewhohavedepressive symptoms.Although it is be-
yond the scope of this study, unguided iCBT has several limi-
tations that should be addressed before it is disseminated as
part of routine care (eg, highdropout rates, small effects com-
paredwith face-to-faceandguided internet interventions, and
possible participant selection bias).
Given the effects found for treatment adherence, future
research should focus on improving retention of participants
in self-guided iCBTprogramswith theaimofmaximizingposi-
tive therapeutic outcomes. Further research is also needed to
examineadditionalmoderators (eg, sleepquality, cognitiveper-
formance, duration of symptoms), long-term outcomes, and
the value of adding therapist or coach support to these treat-
ments. Finally, future studies should focus on the pragmatic
effectiveness of iCBT in routine care settings.
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